| Literature DB >> 29329488 |
Glenda Comai1,2, Agnès Boutet1,3, Kristina Tanneberger4, Filippo Massa1, Ana-Sofia Rocha1, Aurelie Charlet1, Clara Panzolini1, Fariba Jian Motamedi1, Robert Brommage5, Wolfgang Hans5, Thomas Funck-Brentano6,7, Martin Hrabe de Angelis5,8,9, Christine Hartmann10, Martine Cohen-Solal6,7, Jürgen Behrens4, Andreas Schedl1.
Abstract
The X-linked WTX/AMER1 protein constitutes an important component of the β-catenin destruction complex that can both enhance and suppress canonical β-catenin signaling. Somatic mutations in WTX/AMER1 have been found in a proportion of the pediatric kidney cancer Wilms' tumor. By contrast, germline mutations cause the severe sclerosing bone dysplasia osteopathia striata congenita with cranial sclerosis (OSCS), a condition usually associated with fetal or perinatal lethality in male patients. Here we address the developmental and molecular function of WTX by generating two novel mouse alleles. We show that in addition to the previously reported skeletal abnormalities, loss of Wtx causes severe midline fusion defects including cleft palate and ectopic synostosis at the base of the skull. By contrast, deletion of the C-terminal part of the protein results in only mild developmental abnormalities permitting survival beyond birth. Adult analysis, however, revealed skeletal defects including changed skull morphology and an increased whole-body bone density, resembling a subgroup of male patients carrying a milder, survivable phenotype. Molecular analysis in vitro showed that while β-catenin fails to co-immunoprecipitate with the truncated protein, partial recruitment appears to be achieved in an indirect manner using AXIN/AXIN2 as a molecular bridge. Taken together our analysis provides a novel model for WTX-caused bone diseases and explains on the molecular level how truncation mutations in this gene may retain some of WTX-protein functions.Entities:
Keywords: BONE DEVELOPMENT; MOUSE MODELS; OSCS; β-CATENIN SIGNALING
Mesh:
Substances:
Year: 2018 PMID: 29329488 DOI: 10.1002/jbmr.3387
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741